| CXSL1300081 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(15) | New Drug Application | 2013-12-11 | 通化东宝药业股份有限公司 | Tonghua Dongbao Pharmaceutical Co Ltd | Certificate Issued | 2016-01-14 | view |
| CXSL1300078 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(15) | New Drug Application | 2013-12-11 | 通化东宝药业股份有限公司 | Tonghua Dongbao Pharmaceutical Co Ltd | Certificate Issued | 2016-01-14 | view |
| CXSL1700155 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(15) | New Drug Application | 2018-03-21 | 辽宁博鳌生物制药有限公司 | Liaoning Boao Biological Pharmaceutical Co Ltd | In Review | 2018-03-16 | view |
| CYSB1700126 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2017-09-08 | 诺和诺德（中国）制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | Certificate Issued | 2017-11-21 | view |
| CYSB2000101 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2020-05-22 | 诺和诺德（中国）制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | In Review | 2020-06-28 | view |
| CYSB1700050 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2017-09-08 | 诺和诺德（中国）制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | Certificate Issued | 2017-11-21 | view |
| CYSB1100485 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2012-03-07 | 诺和诺德（中国）制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | Certificate Issued | 2013-06-27 | view |
| CXSS1400003 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(15) | New Drug Application | 2014-12-25 | 甘李药业股份有限公司 | Gan & Lee Pharmaceuticals | Certificate Issued | 2018-06-28 | view |
| CXSS1400002 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(15) | New Drug Application | 2014-12-25 | 甘李药业股份有限公司 | Gan & Lee Pharmaceuticals | Certificate Issued | 2020-12-10 | view |
| CXSL0900036 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(15) | New Drug Application | 2010-01-15 | 甘李药业有限公司 | Gan & Lee Pharmaceuticals | Certificate Issued | 2011-11-07 | view |
| CXSL0900035 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(15) | New Drug Application | 2010-01-15 | 甘李药业有限公司 | Gan & Lee Pharmaceuticals | Certificate Issued | 2011-11-07 | view |
| CXSL1100007 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(15) | New Drug Application | 2011-03-30 | 珠海联邦制药股份有限公司中山分公司 | Zhuhai United Laboratories Co Ltd | Certificate Issued | 2013-04-11 | view |
| CXSS1700031 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(15) | New Drug Application | 2018-01-18 | 珠海联邦制药股份有限公司 | Zhuhai United Laboratories Co Ltd | Certificate Issued | 2021-07-16 | view |
| CXSS1700030 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(15) | New Drug Application | 2018-01-18 | 珠海联邦制药股份有限公司 | Zhuhai United Laboratories Co Ltd | Certificate Issued | 2021-07-16 | view |
| CXSL2000109 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(15) | New Drug Application | 2020-05-30 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | In Review | 2020-05-29 | view |
| CXSL1500127 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(15) | New Drug Application | 2016-03-30 | 宜昌东阳光长江药业股份有限公司 | Yichang HEC Changjiang Pharmaceutical Co Ltd | Certificate Issued | 2017-04-20 | view |
| CXSS2100019 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(3.3) | New Drug Application | 2021-02-11 | 宜昌东阳光长江药业股份有限公司 | Yichang HEC Changjiang Pharmaceutical Co Ltd | In Review | 2021-02-10 | view |
| CXSL1700180 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(15) | New Drug Application | 2018-05-07 | 吉林津升制药有限公司 | Ji Lin Jin Sheng Pharmaceutical Co Ltd | Certificate Issued | 2018-09-03 | view |
| CXSL1700222 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(15) | New Drug Application | 2018-04-26 | 北京双鹭药业股份有限公司 | Beijing SL Pharmaceutical Co Ltd | In Review | 2018-04-25 | view |
| J0400579 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2004-09-23 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2004-11-03 | view |
